Utilization of nonguideline concordant antibiotic treatment following acute otitis media in children in the U nited S tates
Pharmacoepidemiology and Drug Safety · 2023-02 · 32 (2) · 256-265
DOI: 10.1002/pds.5554 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 02.11.2022. Verfasst von Leah J McGrath und 6 weiteren Autor:innen. Beteiligte Einrichtung: Inferential Design, LLC, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Otitis Media. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: AHRQ HHS, Agency for Healthcare Research and Quality, NCATS NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Purpose
Acute otitis media (AOM) is a common indication for antibiotics in children. We sought to characterize the frequency of nonguideline concordant antibiotic therapy for AOM in the United States, by agent and duration.
Methods
Using national administrative claims data (2016–2019), we identified children aged 6 months to 17 years with an oral antibiotic dispensed within 3 days of a new diagnosis of suppurative AOM. Use of nonguideline concordant agents and durations, defined based on national treatment guidelines, were summarized by age, race, rurality, region, and insurance type. Subsequent oral antibiotic dispensing within the year after AOM diagnosis was also evaluated. We created sunburst diagrams to visualize longitudinal patterns of within‐person antibiotic utilization for AOM, by agent and duration.
Results
We identified 789 424 eligible commercially‐insured and 502 239 medicaid‐insured children. Among commercially insured children, 35% received nonguideline concordant agents for AOM, including cefdinir (16%), amoxicillin‐clavulanate (12%), and azithromycin (7%). Fewer children age
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inferential Design, LLC, Durham, North Carolina, USA.
- Department of Pediatrics, Denver Health Medical Center, Denver, Colorado, USA.
- Office of Research, Denver Health Medical Center, Denver, Colorado, USA.
- Department of Pediatrics, School of Medicine, University of Colorado, Aurora, Colorado, USA.
- Department of Pediatrics, School of Medicine, Washington University, St. Louis, Missouri, USA.
- Department of Medicine, School of Medicine, Washington University, St. Louis, Missouri, USA.
ORCID-Profile: Leah J McGrath, Holly M Frost, John M Sahrmann, Yinjiao Ma, Anne M Butler
Förderung
- AHRQ HHS
- Agency for Healthcare Research and Quality
- NCATS NIH HHS
- Washington University Institute of Clinical and Translational Sciences
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health & Human Development
- National Center for Advancing Translational Sciences
Zitieren
APA
McGrath, L. J., Frost, H. M., Newland, J. G., O'Neil, C. A., Sahrmann, J. M., Ma, Y., & Butler, A. M. (2023). Utilization of nonguideline concordant antibiotic treatment following acute otitis media in children in the U nited S tates. Pharmacoepidemiology and Drug Safety, 32(2), 256-265. https://doi.org/10.1002/pds.5554
Vancouver
McGrath LJ, Frost HM, Newland JG, O'Neil CA, Sahrmann JM, Ma Y, et al. Utilization of nonguideline concordant antibiotic treatment following acute otitis media in children in the U nited S tates. Pharmacoepidemiology and Drug Safety. 2023;32(2):256-265. doi:10.1002/pds.5554
BibTeX
@article{McGrath2023,
author = {McGrath, Leah J and Frost, Holly M and Newland, Jason G and O'Neil, Caroline A and Sahrmann, John M and Ma, Yinjiao and Butler, Anne M},
title = {Utilization of nonguideline concordant antibiotic treatment following acute otitis media in children in the U nited S tates},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2023},
volume = {32},
number = {2},
pages = {256--265},
doi = {10.1002/pds.5554}
}
EUVIMED